News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
573,762 Results
Type
Article (41598)
Company Profile (122)
Press Release (532033)
Multimedia
Podcasts (78)
Webinars (15)
Section
Business (154941)
Career Advice (2475)
Deals (28236)
Drug Delivery (114)
Drug Development (73728)
Employer Resources (141)
FDA (13960)
Job Trends (12374)
News (276110)
Policy (27453)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2580)
Academic (1)
Accelerated approval (33)
Adcomms (30)
Allergies (138)
Alliances (39361)
ALS (168)
Alzheimer's disease (1684)
Antibody-drug conjugate (ADC) (314)
Approvals (14180)
Artificial intelligence (488)
Autoimmune disease (145)
Automation (38)
Bankruptcy (313)
Best Places to Work (10020)
BIOSECURE Act (17)
Biosimilars (173)
Biotechnology (88)
Bladder cancer (155)
Brain cancer (56)
Breast cancer (612)
Cancer (4647)
Cardiovascular disease (406)
Career advice (2096)
Career pathing (36)
CAR-T (263)
CDC (50)
Cell therapy (705)
Cervical cancer (28)
Clinical research (63339)
Collaboration (1507)
Company closure (4)
Compensation (651)
Complete response letters (65)
COVID-19 (2608)
CRISPR (86)
C-suite (895)
Cystic fibrosis (124)
Data (6063)
Decentralized trials (2)
Denatured (16)
Depression (145)
Diabetes (482)
Diagnostics (6107)
Digital health (39)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (233)
Drug pricing (179)
Drug shortages (26)
Duchenne muscular dystrophy (235)
Earnings (58869)
Editorial (58)
Employer branding (18)
Employer resources (133)
Events (80642)
Executive appointments (995)
FDA (16878)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (21)
Funding (1308)
Gene editing (186)
Generative AI (43)
Gene therapy (597)
GLP-1 (961)
Government (4401)
Grass and pollen (7)
Guidances (379)
Healthcare (16174)
HIV (61)
Huntington's disease (46)
IgA nephropathy (84)
Immunology and inflammation (270)
Immuno-oncology (62)
Indications (109)
Infectious disease (2879)
Inflammatory bowel disease (184)
Inflation Reduction Act (16)
Influenza (113)
Intellectual property (239)
Interviews (532)
IPO (12848)
IRA (54)
Job creations (2649)
Job search strategy (1691)
JPM (55)
Kidney cancer (18)
Labor market (60)
Layoffs (515)
Leadership (37)
Legal (5848)
Liver cancer (91)
Longevity (11)
Lung cancer (658)
Lymphoma (369)
Machine learning (35)
Management (51)
Manufacturing (688)
MASH (178)
Medical device (10955)
Medtech (11001)
Mergers & acquisitions (16349)
Metabolic disorders (1253)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (327)
Neuropsychiatric disorders (95)
Neuroscience (2926)
Neurotech (1)
NextGen: Class of 2026 (5577)
Non-profit (4051)
Now hiring (57)
Obesity (580)
Opinion (276)
Ovarian cancer (161)
Pain (194)
Pancreatic cancer (224)
Parkinson's disease (278)
Partnered (30)
Patents (479)
Patient recruitment (482)
Peanut (50)
People (52949)
Pharmaceutical (23)
Pharmacy benefit managers (19)
Phase 1 (19530)
Phase 2 (27827)
Phase 3 (21216)
Pipeline (5192)
Policy (283)
Postmarket research (2324)
Preclinical (8019)
Press Release (55)
Prostate cancer (228)
Psychedelics (55)
Radiopharmaceuticals (247)
Rare diseases (839)
Real estate (4269)
Recruiting (60)
Regulatory (21450)
Reports (31)
Research institute (2200)
Resumes & cover letters (361)
Rett syndrome (26)
RNA editing (17)
RSV (72)
Schizophrenia (151)
Series A (216)
Series B (169)
Service/supplier (5)
Sickle cell disease (95)
Special edition (18)
Spinal muscular atrophy (155)
Sponsored (38)
Startups (2885)
State (2)
Stomach cancer (19)
Supply chain (90)
Tariffs (75)
The Weekly (61)
Vaccines (961)
Venture capital (86)
Weight loss (385)
Women's health (72)
Worklife (19)
Date
Last 7 days (475)
Last 30 days (1890)
Last 365 days (26374)
2026 (3468)
2025 (26755)
2024 (30767)
2023 (34582)
2022 (45118)
2021 (48435)
2020 (46818)
2019 (39962)
2018 (30293)
2017 (27279)
2016 (26035)
2015 (30341)
2014 (22852)
2013 (18612)
2012 (20017)
2011 (20966)
2010 (18561)
Location
Africa (748)
Alabama (76)
Alaska (4)
Arizona (222)
Arkansas (11)
Asia (35313)
Australia (7334)
California (9617)
Canada (3018)
China (1039)
Colorado (398)
Connecticut (380)
Delaware (317)
Europe (79075)
Florida (1529)
Georgia (302)
Hawaii (3)
Idaho (54)
Illinois (748)
India (63)
Indiana (474)
Iowa (17)
Japan (405)
Kansas (118)
Kentucky (30)
Louisiana (24)
Maine (59)
Maryland (1226)
Massachusetts (6516)
Michigan (285)
Minnesota (483)
Mississippi (4)
Missouri (120)
Montana (24)
Nebraska (24)
Nevada (109)
New Hampshire (76)
New Jersey (2699)
New Mexico (21)
New York (2542)
North Carolina (1207)
North Dakota (6)
Northern California (4672)
Ohio (281)
Oklahoma (10)
Oregon (33)
Pennsylvania (1925)
Puerto Rico (22)
Rhode Island (38)
South America (1010)
South Carolina (61)
South Dakota (1)
Southern California (3815)
Tennessee (144)
Texas (1569)
United States (34051)
Utah (296)
Vermont (1)
Virginia (237)
Washington D.C. (66)
Washington State (792)
West Virginia (4)
Wisconsin (91)
Wyoming (2)
573,762 Results for "celyad formally known as cardio3 biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
February 19, 2026
·
6 min read
Vaccines
CDC Formally Adopts Delayed Hepatitis B Vaccine Dose
The CDC accepted the recommendation of its advisory committee that the shot be delayed for many patients until they are at least two months of age due to safety concerns. The CDC itself has said the vaccine is safe and effective.
December 17, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2026
·
5 min read
Press Releases
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
December 17, 2025
·
7 min read
Press Releases
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
December 23, 2025
·
8 min read
Press Releases
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
January 5, 2026
·
4 min read
Press Releases
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
October 6, 2025
·
7 min read
Business
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
Celyad Oncology (Euronext: CYAD) (the “Company”), today provides a fourth quarter 2023 business update and an outlook for 2024.
January 16, 2024
·
7 min read
Celyad Oncology announces intention to terminate SEC reporting obligations
Celyad Oncology SA announces that it will voluntarily file a Form 15F with the United States Securities and Exchange Commission to terminate its SEC reporting obligations under Section 13 or Section 15 of the Securities Exchange Act of 1934, as amended.
February 8, 2024
·
4 min read
Business
Celyad announces management change - December 04, 2023
Celyad Oncology announces that its CEO and managing director Georges Rawadi has decided to step down, effective as of Friday December 1, 2023.
December 4, 2023
·
3 min read
1 of 57,377
Next
